SD
Sanjay Devidas Patil
About Sanjay Devidas Patil
Data last updated:
Sanjay Devidas Patil is a Director at Genpep Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Genpep Pharmaceuticals Private Limited reported revenue of ₹3.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genpep Pharmaceuticals Private Limited U24299GJ2021PTC122976 | Director | 31 Jan 2022 | 2021 | ₹3.68 Cr (FY 2025) | Active |
Board colleagues of Sanjay Devidas Patil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aashay Jayantilal Patel | 07986307 | Genpep Pharmaceuticals Private Limited | Director |
| Adinath Murlidhar Jain | 09484272 | Genpep Pharmaceuticals Private Limited | Director |
| Hemal Naranbhai Patel | 02456081 | Genpep Pharmaceuticals Private Limited | Director |
| Mahesh Vasant Sonar | 09275061 | Genpep Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Devidas Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Devidas Patil
Sanjay Devidas Patil currently holds 1 directorship: Genpep Pharmaceuticals Private Limited (Director, since 31 Jan 2022, revenue ₹3.68 Cr (FY 2025)).
Sanjay Devidas Patil was first appointed on 31 Jan 2022 as Director at Genpep Pharmaceuticals Private Limited.
The current boards of Sanjay Devidas Patil's companies include Aashay Jayantilal Patel (Genpep Pharmaceuticals Private Limited), Adinath Murlidhar Jain (Genpep Pharmaceuticals Private Limited), Hemal Naranbhai Patel (Genpep Pharmaceuticals Private Limited), Mahesh Vasant Sonar (Genpep Pharmaceuticals Private Limited).